These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34578846)

  • 1. Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer.
    Lin YC; Ling HH; Chang PH; Pan YP; Wang CH; Chou WC; Chen FP; Yeh KY
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy.
    Lin YC; Wang CH; Ling HH; Pan YP; Chang PH; Chou WC; Chen FP; Yeh KY
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy x-ray absorptiometry.
    Jackson W; Alexander N; Schipper M; Fig L; Feng F; Jolly S
    Head Neck; 2014 Sep; 36(9):1356-62. PubMed ID: 23970480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial.
    Lonkvist CK; Lønbro S; Vinther A; Zerahn B; Rosenbom E; Primdahl H; Hojman P; Gehl J
    BMC Cancer; 2017 Jun; 17(1):400. PubMed ID: 28578654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated loss of lean body mass in head and neck cancer patients during cisplatin-based chemoradiation.
    Lønbro S; Gam S; Hermann AP; Hansen CR; Johansen J
    Acta Oncol; 2023 Nov; 62(11):1403-1411. PubMed ID: 37589161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.
    Kimura H; Hamauchi S; Kawai S; Onozawa Y; Yasui H; Yamashita A; Ogawa H; Onoe T; Kamijo T; Iida Y; Onitsuka T; Yokota T
    Int J Clin Oncol; 2020 Feb; 25(2):258-266. PubMed ID: 31620932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Chemotherapy on Dual-Energy X-ray Absorptiometry (DXA) Body Composition Precision Error in Head and Neck Cancer Patients.
    Chang HC; Lin YC; Ng SH; Cheung YC; Wang CH; Chen FP; Chang HP; Sung CM; Fan CM; Yeh KY; Wu JS
    J Clin Densitom; 2019; 22(3):437-443. PubMed ID: 30172603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity, Radiation Duration, and Pretreatment Body Muscle Mass Predict Early Treatment Failure in Taiwanese Patients with Locally Advanced Oral Cavity Squamous Cell Carcinoma after Completion of Adjuvant Concurrent Chemoradiotherapy.
    Lin YC; Ling HH; Chang PH; Pan YP; Wang CH; Chou WC; Chen FP; Yeh KY
    Diagnostics (Basel); 2021 Jul; 11(7):. PubMed ID: 34359287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment-Interval Changes in Serum Levels of Albumin and Histidine Correlated with Treatment Interruption in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Completing Chemoradiotherapy under Recommended Calorie and Protein Provision.
    Wang CH; Ling HH; Liu MH; Pan YP; Chang PH; Lin YC; Chou WC; Peng CL; Yeh KY
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options.
    Iocca O; Farcomeni A; Di Rocco A; Di Maio P; Golusinski P; Pardiñas López S; Savo A; Pellini R; Spriano G
    Oral Oncol; 2018 May; 80():40-51. PubMed ID: 29706187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The application of induction chemotherapy in the treatment of locally advanced head and neck squamous cell carcinoma].
    Zhou L
    Zhonghua Yi Xue Za Zhi; 2024 Jul; 104(26):2373-2377. PubMed ID: 38978359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Appendicular Skeletal Muscle Index for Predicting the Recurrence-Free Survival of Head and Neck Cancer.
    Yeh KY; Ling HH; Ng SH; Wang CH; Chang PH; Chou WC; Chen FP; Lin YC
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33673006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01).
    Lee YG; Kang EJ; Keam B; Choi JH; Kim JS; Park KU; Lee KE; Kwon JH; Lee KW; Kim MK; Ahn HK; Shin SH; Kim HR; Kim SB; Yun HJ
    BMC Cancer; 2020 Aug; 20(1):813. PubMed ID: 32854649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Body Composition Changes and the Importance of Fat-Free Mass Index in Locally Advanced Nasopharyngeal Carcinoma Patients Undergoing Concurrent Chemoradiotherapy.
    Ding H; Dou S; Ling Y; Zhu G; Wang Q; Wu Y; Qian Y
    Integr Cancer Ther; 2018 Dec; 17(4):1125-1131. PubMed ID: 30345816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nutritional surveillance in head and neck cancer patients during radiotherapy--the difference between concurrent chemoradiotherapy using high-dose cisplatin and radiotherapy alone].
    Nakahara S; Yoshino K; Fujii T; Uemura H; Suzuki M; Nishiyama K; Inohara H
    Nihon Jibiinkoka Gakkai Kaiho; 2012 Oct; 115(10):902-9. PubMed ID: 23214048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.
    Mohamed A; Twardy B; Zordok MA; Ashraf K; Alkhoder A; Schrapp K; Steuer C; Chen Z; Pakkala S; Pillai R; Trad Wadsworth J; Higgins K; Beitler JJ; Ramalingam SS; Owonikoko TK; Khuri FR; Shin DM; Behera M; Saba NF
    Head Neck; 2019 May; 41(5):1490-1498. PubMed ID: 30835900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma.
    Willemsen ACH; Hoeben A; Lalisang RI; Van Helvoort A; Wesseling FWR; Hoebers F; Baijens LWJ; Schols AMWJ
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):145-159. PubMed ID: 31536685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional changes in patients with locally advanced head and neck cancer during treatment.
    Arribas L; Hurtós L; Taberna M; Peiró I; Vilajosana E; Lozano A; Vazquez S; Mesia R; Virgili N
    Oral Oncol; 2017 Aug; 71():67-74. PubMed ID: 28688694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.